Genomic Basis of Neurodevelopmental and Brain Outcomes in Congenital Heart Disease (CHD Brain and Genes)



Status:Recruiting
Conditions:Cardiology, Cardiology
Therapuetic Areas:Cardiology / Vascular Diseases
Healthy:No
Age Range:8 - Any
Updated:2/15/2018
Start Date:September 18, 2017
End Date:December 2022
Contact:Marianne Hird
Email:marianne.hird@cchmc.org
Phone:513-517-0279

Use our guide to learn which trials are right for you!

Genomic Basis of Neurodevelopmental and Brain Outcomes in Congenital Heart Disease

Approximately 400 Congenital heart disease patients will participate in the research study
which will include one or more research visits for neurodevelopmental testing, brain MRI, and
collection of medical history including previously collected genetic sequencing results. The
investigators will explore the association between genetic variants, neurodevelopmental
deficits, and brain MRI endophenotype. Analyses will compare groups with and without
deleterious de novo mutations.


Inclusion Criteria:

1. Subjects in whom whole exome sequencing or whole genome sequencing has already been
performed, either during the CHD GENES study or, for new centers (Utah or
USCF/Stanford), after trios in existing biobanks undergo analysis by whole exome
sequencing or whole genome sequencing during the Pediatric Cardiac Genomic Consortium
2 grant cycle

2. Presence of deleterious mutations (damaging de novo mutations or stringently defined
deleterious missense mutations) identified on sequencing (Cases) OR absence of such
known deleterious mutations (Controls)

3. Males or females, age ≥8 years

4. Diagnosis of congenital heart disease

5. Informed consent obtained

Exclusion Criteria:

1. History of cardiac transplant

2. A cardiac surgical procedure within 6 months of enrollment

3. Known clinical genetic syndrome, characterized as a monogenic condition with an
identified gene associated with abnormalities of the brain structure or function,
structural heart disease, and potentially other associated features.

4. Presence of CNV known to be clinically pathogenic. Variants will be classified as
pathogenic using accepted types of variant evidence (e.g., population data,
computational data, functional data, segregation data) as detailed in the American
College of Medical Genetics and Genomics " Standards and Guidelines for the
interpretation of sequence variants" (Richards et al, GIM 2015).

5. Overwhelming acquired brain injury, such as a major stroke or severe ischemic injury,
that would overshadow the effect of a genetic mutation on outcome in the opinion of
the center investigator

6. Lack of reading fluency in English or Spanish
We found this trial at
8
sites
South 34th Street
Philadelphia, Pennsylvania 19104
 215-590-1000
Principal Investigator: Elizabeth Goldmuntz, MD
Phone: 267-426-7484
Children's Hospital of Philadelphia Since its start in 1855 as the nation's first hospital devoted...
?
mi
from
Philadelphia, PA
Click here to add this to my saved trials
4650 Sunset Blvd
Los Angeles, California 90027
 (323) 660-2450
Principal Investigator: Richard W Kim, MD
Phone: 323-361-6355
Childrens Hospital Los Angeles Children's Hospital Los Angeles is a 501(c)(3) nonprofit hospital for pediatric...
?
mi
from
Los Angeles, CA
Click here to add this to my saved trials
60 Crittenden Blvd # 70
Rochester, New York 14642
(585) 275-2121
Principal Investigator: George Porter, MD, PhD
Phone: 585-273-4168
University of Rochester The University of Rochester is one of the country's top-tier research universities....
?
mi
from
Rochester, NY
Click here to add this to my saved trials
201 Presidents Circle
Salt Lake City, Utah 84108
801) 581-7200
Principal Investigator: Thomas A. Miller, DO
Phone: 801-213-7610
University of Utah Research is a major component in the life of the U benefiting...
?
mi
from
Salt Lake City, UT
Click here to add this to my saved trials
Boston, Massachusetts 02115
Principal Investigator: Jane Newburger, MD
Phone: 617-355-4979
?
mi
from
Boston, MA
Click here to add this to my saved trials
New Haven, Connecticut 6520
(203) 432-4771
Principal Investigator: Abha Gupta
Phone: 203-737-6835
Yale University Yale's roots can be traced back to the 1640s, when colonial clergymen led...
?
mi
from
New Haven, CT
Click here to add this to my saved trials
New York, New York 10029
Principal Investigator: Bruce D. Gelb, MD
Phone: 212-241-6012
?
mi
from
New York, NY
Click here to add this to my saved trials
San Francisco, California 94143
Principal Investigator: Patrick McQuillen, MD
Phone: 415-502-4798
?
mi
from
San Francisco, CA
Click here to add this to my saved trials